Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Voyager Therapeutics Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q4, Voyager Therapeutics (NASDAQ:VYGR) earned $5.71 million, a 122.71% increase from the preceding quarter. Voyager Therapeutics also posted a total of $28.07 million in sales, a 1771.53% increase since Q3. Voyager Therapeutics collected $1.50 million in revenue during Q3, but reported earnings showed a $25.14 million loss.

What Is ROCE?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.